56
Process Chemistry: From Millimole to Kilomole Kevin P. Schultz Nelsen Group April 6, 2006

Plugin Schultz Sem

  • Upload
    amgads

  • View
    232

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Plugin Schultz Sem

Process Chemistry: From Millimole to KilomoleKevin P. SchultzNelsen GroupApril 6, 2006

Page 2: Plugin Schultz Sem

2

OutlineWhat is Process Chemistry?

Drug Development Timeline and Cost

General Considerations

Emend®From Discovery to Scale-Up

Conclusion

Page 3: Plugin Schultz Sem

3

What is Process Chemistry?

N

O O

N

Cl

Claritin®Schering-Plough

HN

O

N

CO2

HO

HO

F

Lipitor®Pfizer

HN

HN NO

N

O O

F

CF3

CF3

Emend®Merck

HN

Cl

Cl

HCl

Zoloft®Pfizer

SafeEnvironmentally friendly

Efficient Economical ($ and atom)

Page 4: Plugin Schultz Sem

4

Process Chemistry

“Process Chemistry is usually equated with scale-up, but characterizing process chemistry simply as the scale-up of a synthetic route does a grave disservice to the organic chemists who have chosen to focus their creative efforts in this field.”

- Celia M. Henry, Senior Editor

C&E News

Henry, C. M. C&E News May 26, 2002, pg 53-66.

Page 5: Plugin Schultz Sem

5

Drug Development TimelineAverage of 12-15 yrs

Target Screen(s) Hit

LeadCandidate Launch

PatentExpiration

P A T E N T

D I S C O V E R Y

C L I N I C A L

SAFETY/PHARMACEUTICAL STUDIES

P R O C E S S R E S E A R C H

4.5 yrs 2 yrs200-300 gms < 100 kg 100-2000 kg

8.2 years

Gadamasetti, Kumar G. Process Chemistry in the PharmaceuticalIndustry. Marcel Dekker, Inc. New York: 1999.

Page 6: Plugin Schultz Sem

6

Total Drug Development Cost$400 - $800 million per approved drug

DeMasi, J. A. et al. J. Health Economics 2003, 22, 51–185.

Page 7: Plugin Schultz Sem

7

Patent protection for 20 years

Need For Efficient Process Chemistry

http://www.fda.gov/cder/index.html

Generic drug application: Abbreviated New Drug Application (ANDA)

Page 8: Plugin Schultz Sem

8

Presidential Green Chemistry Challenge Award

Established in 1995 by the EPAFor innovations in cleaner, cheaper and smarter chemistry

www.epa.gov/greenchemistry/presgcc.htmlhttp://pubs.acs.org/cen/coverstory/8026/8026greenchemistry.html

HN

N

O

H2N

N

N

OOH

HO

Cytovene®2000 Roche Corp.

Reduced liquid waste: 1120 metric tons / yearReduced solid waste: 25 metric tons / year

HN

Cl

Cl

HCl

Zoloft®2002 Pfizer, Inc.Reduced waste:

HCl (conc): 150 metric tons / yearTiO2: 440 metric tons / year

HN

HN NO

N

O O

F

CF3

CF3

Emend®2005 Merck

Reduced waste:340,000 L / metric ton

Page 9: Plugin Schultz Sem

9

OutlineWhat is Process Chemistry?

Drug Development Timeline and Cost

General Considerations

Emend®From Discovery to Scale-Up

Conclusion

Page 10: Plugin Schultz Sem

10

General Considerations for Process ChemistryAvoid column chromatography

Seeding helps crystallization

Avoid desiccants, use azeotrope

Avoid solvents with flash point < 15 ºCEther, hexanes, DCM

Temperature range -40 to 120 ºC

Avoid protecting groups

Impurities of > 0.1% must be analyzed

Page 11: Plugin Schultz Sem

11

OutlineWhat is Process Chemistry?Drug Development Timeline and CostGeneral ConsiderationsEmend®

Discovery SynthesisRefined Process Chemistry Route2nd Generation SynthesisCommercial Synthesis

Conclusion

Page 12: Plugin Schultz Sem

12

Emend® - Aprepitant

hNK1 receptor antagonist (IC50 = 0.09 nM)1

Treatment of chemotherapy-induced emesis2

FDA approval in 20032005 Presidential Green Chemistry Challenge Award3

Entered preclinical trials in 19931

1 Hale, J. J. et al; J. Med. Chem. 1998, 41, 4607-4614. 2 Rupniak, N. M. et al; Eur. J. Pharmacol. 1997, 326, 201-209.3 http://www.epa.gov/greenchemistry/past.html

HNNH

N

O

CF3

CF3

O

N

O

F

2

3

Page 13: Plugin Schultz Sem

13

O

N

O

CF3

CF3

F

Me

HN

HN NO

O

NH

O

CF3

CF3

F

Me

O NH

O

N

H2NCl

O

N

O

Ph

CF3

CF3

F

Me

O

N

O

Ph

H2C

CF3

CF3

F

O

N

O

Ph

O

CF3

CF3

F

O

N

O

Ph F

Discovery Synthesis Route

Hale, J. J. et al; J. Med. Chem. 1998, 41, 4607-4614.

Page 14: Plugin Schultz Sem

14

OHO

F

ONH

O

Ph

ON

F

OO

Ph

83%

1) KHMDS

ON

OO

Ph

F

N3

67%92% de

S

2) O

O

N3

1) LiOH2) HCl3) H2, Pd/C

F

H2N

OHOPhCHONaOHNaBH4

F

HN

OHO

Ph

BrBr

(i-Pr)2NEtDMF

F

N

OO

Ph74% (two steps)92% ee

1)

2) HCl

Discovery Synthesis: Oxazinone

40% overall yieldHale, J. J. et al. J. Med. Chem. 1996, 39, 1760-1762.

Evans, D. A.; Britton, T. C.; Ellman, J. A.; Dorow, R. L. J. Am. Chem. Soc. 1990, 112, 4011-4030

Page 15: Plugin Schultz Sem

15

OH

NH

Ph

F

O

H

Na2S2O5,NaCN

H2O, MeOH

F

CN

N

HO

Ph

HCl(g)

F

N

Ph

O NH

HCl

1.2 eq H2O

F

N

Ph

O O

HClKHCO3

F

N

Ph

O O

in i-PrOAc

racemate

1)

2)

One-Pot Synthesis of Oxazinone

> 1.2 eq H2O

F

N

Ph

HO OHO

- Washed aminonitrile with 15 wt % NaCl

Nelson, T. D.; Bhupathy, M. European Patent 1112259, 2001.

80% yield

Page 16: Plugin Schultz Sem

16

Dynamic Resolution

N

Ph

(S)

F

O O1.2 eq

SO3H

O

Br

(-) - BCSA

i-PrOAc, refluxN

Ph

(S)

F

O O

BCSA

99% de90% yield

N

Ph

(R)

F

O O

NH3toluene

N

Ph

(S)

F

O O

BSCA NH4i-PrOAc, HCl

Alabaster, R. J.; Gibson, A. W.; Johnson, S. A.; Edwards, J. S.;Cottrell, I. F. Tetrahedron: Asymmetry 1997, 8, 447-450

Page 17: Plugin Schultz Sem

17

O

N

O

CF3

CF3

F

Me

HN

HN NO

O

NH

O

CF3

CF3

F

Me

O NH

O

N

H2NCl

O

N

O

Ph

CF3

CF3

F

Me

O

N

O

Ph

H2C

CF3

CF3

F

O

N

O

Ph

O

CF3

CF3

F

O

N

O

Ph F

Discovery Synthesis Route

Page 18: Plugin Schultz Sem

18

Acyl Acetal Formation

F

(S)

N

Ph

O O

F

N

Ph

O O

F

N

Ph

OO H

F

N

Ph

O O

> -60 oC

CF3

CF3Cl

O

< -60 oC

F

(S)(R)

N

Ph

O O

O

CF3

CF3

99% de82% yield

CF3

CF3Cl

OF

(S)(S)

N

Ph

O O

O

CF3

CF3

L-SelectrideTHF/toluene> -60 oC

L-SelectrideTHF/toluene< -60 oC

strict cryogenic temperatures

Ashwood, M. S.; Cottrell, I. F.; Davies, A. J. Tetrahedron: Asymmetry 1997, 8, 957.

Page 19: Plugin Schultz Sem

19

O

N

O

CF3

CF3

F

Me

HN

HN NO

O

NH

O

CF3

CF3

F

Me

O NH

O

N

H2NCl

O

N

O

Ph

CF3

CF3

F

Me

O

N

O

Ph

H2C

CF3

CF3

F

O

N

O

Ph

O

CF3

CF3

F

O

N

O

Ph F

Discovery Synthesis Route

Page 20: Plugin Schultz Sem

20

TiCl

Cl

MeMgClTi

Me

Me

heat

-CH4Ti CH2

TiMe

Me

energeticdecomposition

decomposes insolid state

-5 to -10 oC

titanium carbenereactive and unstable

O

R OR'

R OR'

TiO

Cp Cp

CH2

R OR'

TiO

Petasis Reagent

>2 eq of Petasis reagent necessary

Petasis Reagent

TiMe

Meexcess

TiO

Ti

major byproduct

TiCl

Cl

HCl

recycle

Ti CH2

undesiredproducts

excess

Hughes, D. L.; Payack, J. F.; Cai, D.; Verhoeven, T. R.; Reider, P. J. Organometallics 1996, 15, 663.Payack, J. F. et al Org. Proc. Res. Develop. 2004, 8, 256.

Page 21: Plugin Schultz Sem

21

Sacrificial Ester

TiMe

Me

F

(S)(R)

N

Ph

O O

O

CF3

CF3

F

(S)(R)

N

Ph

O O

CF3

CF3

Ti

O

Cp

Cp

F

(S)(R)

N

Ph

O O

H2C

CF3

CF3

Ti

92%

80 oC

THF/toluene

OTi

O

O

F

(S)(R)

N

Ph

O O

<Ph

O

CF3

CF3

O

OPh0.75 eq

Payack, J. F. et al Org. Proc. Res. Develop. 2004, 8, 256.

Page 22: Plugin Schultz Sem

22

O

N

O

CF3

CF3

F

Me

HN

HN NO

O

NH

O

CF3

CF3

F

Me

O NH

O

N

H2NCl

O

N

O

Ph

CF3

CF3

F

Me

O

N

O

Ph

H2C

CF3

CF3

F

O

N

O

Ph

O

CF3

CF3

F

O

N

O

Ph F

Discovery Synthesis Route

Page 23: Plugin Schultz Sem

23

Hydrogenation

F

(S)(R)

N

Ph

O O

H2C

CF3

CF3 Pd/Al2O3,H2

F

(S)(R)

N

Ph

O O

(R)

CF3

CF3

F

(S)(R)

N

Ph

O O

(S)

CF3

CF3

+

Me Me

Pd/Al2O3,TsOH, H2

F

(S)(R)

NH

O O

(R)

CF3

CF3Me

F

(S)(R)

NH

O O

(S)

CF3

CF3Me

TsOH TsOH

91 : 9

EtOH:EtOAc1:1

F

(S)(R)

N

O O

CF3

CF3

TsOH

O

86% yield99% de

Nelson, T. D. Synthesis of Aprepitant. Strategies and Tactics in Organic Synthesis;Harmata, M., Ed.; Elsevier: San Diego; 2005: pp 321-351.

Page 24: Plugin Schultz Sem

24

O

N

O

CF3

CF3

F

Me

HN

HN NO

O

NH

O

CF3

CF3

F

Me

O NH

O

N

H2NCl

O

N

O

Ph

CF3

CF3

F

Me

O

N

O

Ph

H2C

CF3

CF3

F

O

N

O

Ph

O

CF3

CF3

F

O

N

O

Ph F

Discovery Synthesis Route

Page 25: Plugin Schultz Sem

25

Triazolinone Ring

F

(S)(R)

NH

O O

(R)

CF3

CF3Me

F

(S)(R)

N

O O

(R)

CF3

CF3Me

NNH

O

H2NO

xylenes140oC

F

(S)(R)

N

O O

(R)

CF3

CF3Me

N

HN

HN

O

aprepitant85%

NH

O

ON

H2N

Cl

K2CO3, toluene, DMSO

- A single SN2 displacement was envisioned- Charcoal treatment

Hale, J. J. et al; J. Med. Chem. 1998, 41, 4607-4614.

Page 26: Plugin Schultz Sem

26

Facile Addition of Triazolinone Ring

commerciallyavailable

HN

NH2

H2N

O

OOO

Cl

MeOH, 20oC

3 days

HN

NH

NO

Cl

90%HCl

F

(S)(R)

NH

O O

(R)

CF3

CF3Me

F

(S)(R)

N

O O

(R)

CF3

CF3

Me

N

HN

HN

O

aprepitant98%

HN

NH

N

ClO

K2CO3, DMF, 1hr, RT

Cowden, C. J. et al Tetrahedron Lett. 2000, 41, 8661.

Page 27: Plugin Schultz Sem

27

1st Generation Synthesis: 1993-199943% overall yield (longest linear sequence)Clinical trials

Larger doses necessary Good results for antiemesisPossible antidepressant

Key improvement areasChiral Acid – BCSA

Expensive (1kg NH4 salt= $4500)Unreacted acid lost

L-SelectrideExpensiveStrict cryogenic temperatures

Dimethyl titanoceneExpensiveToxic

NO NEW IMPURITIES

Nelson, T. D. Synthesis of Aprepitant. Strategies and Tactics in Organic Synthesis;Harmata, M., Ed.; Elsevier: San Diego; 2005: pp 321-351.

Page 28: Plugin Schultz Sem

28

OutlineWhat is Process Chemistry?Drug Development Timeline and CostGeneral ConsiderationsEmend®

Discovery SynthesisRefined Process Chemistry Route3rd Generation SynthesisCommercial Synthesis

Conclusion

Page 29: Plugin Schultz Sem

29

Logical 3rd Generation Retrosynthesis

N

F

O O

CF3

CF3

NNH

HN

O

N

F

O O

CF3

CF3

NNH

HN

OCl

P

CF3

CF3

OH

N

F

O

P

LG

Zhao, M. M. et al. J. Org. Chem. 2002, 67, 6743-6747.

Page 30: Plugin Schultz Sem

30

Cis Acetalization Approach

N

O

Ph

O

F

DIBALH

N

O

Ph

OH

F

N

O

Ph

OR

F

1) base

2) RCl

R= C(O)CH3 C(O)CF3 C(NH)CCl3

F3C

CF3

OH

Me

Lewis Acid

N

O

Ph F

O

CF3

CF3

N

O

Ph F

-trans acetalization and elimination products

Zhao, M. M. et al. J. Org. Chem. 2002, 67, 6743-6747.Ashwood, M. S.; Cottrell, I. F.; Davies, A. J. Tetrahedron: Asymmetry 1997, 8, 957-963.

Page 31: Plugin Schultz Sem

31

3rd Generation Retrosynthesis

N

F

O O

CF3

CF3

NNH

HN

O

NH

F

O O

CF3

CF3

NNH

HN

O

Cl

N

F

O O

CF3

CF3

N

F

O O

NH

CCl3

Ph

CF3

CF3

OH

N

F

O

Ph

O

F

O

OH

OH

Ph NH

OH

Zhao, M. M. et al. J. Org. Chem. 2002, 67, 6743-6747

Page 32: Plugin Schultz Sem

32

F

O

O AcOH /

i-PrOAc

F

O

N

O

(R)

Ph F

(R)

O

N

O

(R)

Ph

2 : 1(3S) : (3R)

HCl

90%98% de

HCl

i-PrOAc70 oC

OH

NH(R)

Ph

N

OOH

F

Ph

N(R)

Ph

OHO

F

3rd Generation Synthesis

Zhao, M. M. et al. J. Org. Chem. 2002, 67, 6743-6747Agami, C.; Couty, F.; Prince, B.; Venier, O. Tetrahedron Lett 1993, 34, 7061-7062

Page 33: Plugin Schultz Sem

33

BF3 Et2O

F

(R)

O

N

O

Ph

DIBALH

F

(R)(S)

O

N

OH

Ph

toluene/THF-20oC

trans / cis8 / 1

CCl3CN

K2CO3

F

O

N

O

Ph

NH

CCl3

CF3

CF3

HO

F

O

N

O

Ph

CF3

CF31) H2, 5% Pd / C

TsOH H2O, toluene/EtOH

2) NCS, DMF, K2CO3, 0oC, 0.5hrs

3) DBU 85% (three steps)trans / cis

96 / 4

F

O

N

O

CF3

CF3

3rd Generation Synthesis: trans Acetalization

Zhao, M. M. et al. J. Org. Chem. 2002, 67, 6743-6747

-Difficult to remove CCl3CN-Shifts back to SM

N

Nelson, T. D. Synthesis of Aprepitant. Strategies and Tactics in Organic Synthesis;Harmata, M., Ed.; Elsevier: San Diego; 2005: pp 321-351.

N

Page 34: Plugin Schultz Sem

34

3rd Generation Synthesis:cis Hydrogenation

Zhao, M. M. et al. J. Org. Chem. 2002, 67, 6743-6747Cowden, C.J. et al. Tetrahedron Lett. 2000, 41, 8661-8664.

F

O

N

O

CF3

CF3

F

O

NH

O

CF3

CF3HN

HN N

ClO

K2CO3 / DMF N

F

O O

CF3

CF3

NNH

HN

OAprepitant98%

81% (four steps)>99% cis

H2

5% Pd / C

Page 35: Plugin Schultz Sem

35

Pros/Cons of 3rd Generation Synthesis

Pros:52% yield (longest linear sequence)Cheap, available starting materialsNo cryogenic temperatures

Cons:Removal of trichloroacetonitrileInversion of C3 stereocenterOperationally lengthy synthesis (12 steps)

Page 36: Plugin Schultz Sem

36

OutlineWhat is Process Chemistry?Drug Development Timeline and CostGeneral ConsiderationsEmend®

Discovery SynthesisRefined Process Chemistry Route3rd Generation SynthesisCommercial Synthesis

Conclusion

Page 37: Plugin Schultz Sem

37

Commercial ScaleRetrosynthetic Analysis

N

F

O O

CF3

CF3

NNH

HN

O

NH

F

O O

CF3

CF3

NNH

HN

OCl

N

O O

CF3

CF3

O

Ph

N

O O

O

Ph

O CF3

CF3

CF3

OH

3

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135

Solve deprotonationproblem with adjacent sp2

center (C3)Dynamic Resolution

Page 38: Plugin Schultz Sem

38

Commercial Scale Synthesis

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135

OH

NH

Ph

OHO

O

N

OCOOH

Ph

N

O

O

OH

Ph

76%

THF/H2O heat2.3 eq

OH

N

Ph

O

OH

Page 39: Plugin Schultz Sem

39

N

O

O

OH

Ph

O

O

O

CF3F3C

CH3CNN

O

O

O

Ph

OF3C

F3C CF3

(R)HO

CH3CN

0.5 eq BF3 Et2O1)

2) NaOH

N

(R)O

O

O

Ph

(R)

CF3

CF3

N

(S)O

O

O

Ph

(R)

CF3

CF3

55 : 45

Commercial Scale Synthesis Cont.

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135

95% overall yield

Page 40: Plugin Schultz Sem

40

Equilibration Studies

N

(R)O

O

O

Ph

(R)

CF3

CF3

N

(S)O

O

O

Ph

(R)

CF3

CF3

65 : 35

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135

Page 41: Plugin Schultz Sem

41

Crystallization-Induced Asymmetric Transformation

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135. Anderson, N. G. Org. Proc. Res. Dev. 2005, 9, 800-813.

N

O

O

O

Ph

CF3

CF3

55 : 45 R : S

1)Δ , -CH3CN +heptane

2) OH0.9 eq

3) -10 to -5 oC, seed with R diastereomer

4) O-K+0.3 eq

5 hours

N

(R)O

O

O

Ph

CF3

CF3

84% yield> 99% de

Page 42: Plugin Schultz Sem

42

CF3

CF3

OO

N O

Ph

Me

MgBr

F

CF3

CF3

OO

NH

Me

F

THF

91%>300 : 1

cis : trans

CF3

CF3

OO

N

Ph

Me

F

OMgBr

1) MeOH2) Pd/C, H2, 1.5eq TsOH

CF3

CF3

OO

N

Me

F

CF3

CF3

OO

NH

Me

F

TsOH

Nucleophilic Addition

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135. Brands, K. M. J. et al. Org. Proc. Res. Dev. 2006, 10, 109-117.

-Unacceptable levels of defluorinated product

CF3

CF3

OO

NH

Me

0.5%

Page 43: Plugin Schultz Sem

43

DefluorinationCF3

CF3

OO

Me

F

N

Pd*

CF3

CF3

OO

Me

Pd

N

F

CF3

CF3

OO

Me

H

N

H2

CF3

CF3

OO

NH

Me

F

H2

CF3

CF3

OO

NH

Me

H

Brands, K. M. J. et al. Org. Proc. Res. Dev. 2006, 10, 109-117.

Catalyst decreased to 3-6wt% Increase H2 pressure to 20psi Gas-liquid mass transfer rate increased Defluorinated product becomes <0.1%

Page 44: Plugin Schultz Sem

44

Final Step: Triazolinone

F

NH

O O

CF3

CF3 HN

NH

NO

Cl

K2CO3DMF / H2O

F

N

O O

CF3

CF3

HN

NH

NO

Aprepitant98%

Cowden, C. J. et al Tetrahedron Lett. 2000, 41, 8661.

Page 45: Plugin Schultz Sem

45

Presidential Green Chemistry Challenge Award - 2005

Convergent synthesisOverall yield 55% (6 steps)Uses 20% of raw materials as original synthesis Reduce waste by 85%

340,000L / metric ton aprepitant

http://www.epa.gov/greenchemistry/past.htmlC&E News June 27, 2005 pg 40-43

N

O OH

O

Ph

CF3

CF3

OH

HNNH

N

O

F

BrMg

CF3

CF3

O

N

O

F

HNNH

N

O

Cl

Page 46: Plugin Schultz Sem

46

OutlineWhat is Process Chemistry?Drug Development Timeline and CostGeneral ConsiderationsEmend®

Discovery SynthesisRefined Process Chemistry Route3rd Generation SynthesisCommercial Synthesis

Conclusions

Page 47: Plugin Schultz Sem

47

Emend® Process Research

10 years of process research

4 synthetic generations

Increased yield from 12% to 55%

Eliminated toxic chemicals

Reduced waste

Developed prior to drug launch

Page 48: Plugin Schultz Sem

48

Conclusion

Process chemistry is more than just scale-upSafe

Cost effective

Environmentally friendly

Timely development

Page 49: Plugin Schultz Sem

49

Acknowledgements

Prof. Stephen F. NelsenNelsen Group Members

Mike WeaverYun LuoGaoquan LiBrian Schuld

Kim Schultz

Practice Talk AttendeesKatie AlfareErik HadleyCaroline PharrWill PomerantzVicki Wilde

Soo Hyuk Choi

Page 50: Plugin Schultz Sem

50

Page 51: Plugin Schultz Sem

51

Crystal Structure of CIAT product (slide 41)

Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135

Page 52: Plugin Schultz Sem

52

Crystal Structure of Aprepitant

O(R)

(S)

N

H

O

H

RF

(R)

CF3F3C

N(S)

(R)

O

HO R

F

(R)

F3C

F3C Brands, K. M. J. et al. J. Am. Chem. Soc. 2003, 125, 2129-2135

Page 53: Plugin Schultz Sem

53

Modified Strecker Reaction (slide 15)

F

O

HNa2S2O5

H2OF

OH

NaO3SCN-

F

CN

HO

NH

OH

F

CN

N

OH1) HCl(g) H2O2) KHCO3

F

N

O O

Page 54: Plugin Schultz Sem

54

Trizolinone Ring Synthesis (Slide 26)

HN

NH2

H2N

O

OOO

Cl

HN

NH

NO

Cl

90%

H

12

HN

NH

H2N

O O

O Cl

H

HN

N

H2N

O

O

Cl

H

HN

N

H2N

O

Cl

OOO

Cl

H

Cl Cl Me OOO

Cl

HH

O

O

Cl

Decomposition:

Page 55: Plugin Schultz Sem

55

3rd Generation Synthesis of Oxazinone Mechanism (slide 32)

F

O

OOH

NH(R)

Ph

O

N(R)

Ph

OH

F

O

N(R)

Ph

O

F1

2

Agami, C.; Couty, F.; Prince, B.; Venier, O. Tetrahedron Lett 1993, 34, 7061-7062.

Page 56: Plugin Schultz Sem

56

Lactam Lactol Synthesis (slide38)OH

NH

Ph

HOO

OH N

Ph

OH2

OHOHO

N

Ph

OHOHO

N

O

Ph

NH

O

O

O

OH

OH

H

HNH

O

O

HO

H

N

O

O

OH

Ph

H